Melanoma — the most serious form of skin cancer — is becoming increasingly common, according to the May issue of Mayo Clinic Women’s HealthSource. Just 45 years ago, 1 in 600 people in the United States had a chance of getting melanoma during his or her lifetime. By 1980, the lifetime risk had risen [...]
Also tagged 45 Years, Face, Healthsource, Lifetime Risk, Mayo Clinic Women, Melanoma, Skin Cancer
Results released from a landmark national survey of dermatologists and consumers unveiled that there is a major gap between what dermatologists recommend and what Americans actually do when it comes to sun-safe behavior. This gap further highlights the need for continued education to reverse the skin cancer epidemic in the United States…
Also tagged Cancer Epidemic, Consumers, Continued Education, Dermatologists, Education Results, Gap, Landmark Survey, Major Gap, National Survey, Skin Cancer, Sun
Fit in Your Skin™, a first-of-its-kind health and wellness program specifically designed for people living with psoriasis, is being introduced today through a collaborative effort between Centocor Ortho Biotech Inc. and the National Psoriasis Foundation (NPF). According to the NPF, psoriasis is the most prevalent autoimmune disease in the United States, affecting as many [...]
Also tagged Autoimmune Disease, Centocor, Collaborative Effort, First Health, Fit, Health And Wellness, Health Wellness, National Psoriasis Foundation, Ortho Biotech, Psoriasis, Skin Health, Wellness Program
GlaxoSmithKline and Ann Arbor-based NanoBio Corporation have announced that they have signed an exclusive over-the-counter licensing agreement for NanoBio’s unique nanoemulsion treatment for cold sores in the United States and Canada. James R. Baker, Jr., M.D…
Also tagged Ann Arbor, Canada, Glaxosmithkline, Licensing Agreement, Milestone, Nanobio, R Baker, Treatment For Cold Sores
Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV™ (telavancin) in the United States. On September 11, 2009, the U.S. Food and Drug Administration (FDA) approved VIBATIV for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus [...]
Also tagged Adult Patients, Astellas Pharma Us, Astellas Pharma Us Inc, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Gram Positive Bacteria, Launch, Mrsa, Nasdaq, September 11, Skin And Skin, Skin Structure Infections, Staphylococcus Aureus, Strains, Telavancin, Theravance Inc, Thrx
Face and Hand Transplants – Ready to Become Mainstream Medicine? Though once inconceivable, face and hand transplants are quickly making themselves more present, both in the operating room and in the media. The world’s first hand transplant was performed more than a decade ago, and the first partial-face transplant performed [...]
Also tagged Decade, First Hand Transplant, First Partial Face Transplant, Hand Transplants, Mainstream Medicine, Medicine, News Briefs, Operating Room, Partial Face Transplant, Plastic Surgery
The U.S. Food and Drug Administration approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis. Plaque psoriasis is an immune system disorder that results in the rapid overproduction of skin cells. About 6 million people in the United States have plaque psoriasis which is characterized [...]
Also tagged 6 Million, Adults, Fda, Food And Drug, Food And Drug Administration, Immune System Disorder, Overproduction, Patches, Plaque Psoriasis, Psoriasis, Red Skin, Silvery Scales, Skin Cells
Palomar Medical Technologies Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, announced that it has become the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, laser device for the treatment of periorbital [...]
Also tagged Consumers, Cosmetic Treatments, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Laser Device, Laser Treatment, Medical Technologies Inc, Nasdaq, Otc, Palomar Medical Technologies, Palomar Medical Technologies Inc, Researcher, Wrinkle Removal, Wrinkles
Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it will exhibit at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) conference in Dallas April 26-29. This conference is regarded industry wide as the premier educational wound-care focused program and has [...]
Also tagged Advanced Wound Care, Care Clinicians, Innovations, Llc, Management Technologies Inc, Otc Bulletin Board, Presentation, Subsidiary, Symposium, Wound Healing Society, Wound Management
According to the National Rosacea Society, there are more than 14 million people in the United States with rosacea, yet only a small number are being treated. Rosacea is a chronic condition that often requires extended treatment periods which often cause side effects, and treatments that provide sustained relief of the signs and symptoms of [...]
Also tagged Chronic Condition, National Rosacea Society, People, Rosacea Sufferers, Signs And Symptoms, Treatment Periods
